Literature DB >> 33361020

Calycosin reduces infarct size, oxidative stress and preserve heart function in isoproterenol-induced myocardial infarction model.

Jie Huang1, Hongyuan Shen1, Mi Jiang1, Lihua Huang1, Yuan Yuan1, Qian Wang1.   

Abstract

Calycosin (CC) is a phytoestrogen, isolated from Radix astragali a well-known Chinese herb and used for treating various pathological conditions. The current study was projected to elucidate the cardio-preservative property of CC in isoproterenol (ISO) induced cardiac injury model (MI) in rats. Male SD rats (n=48) were equally divided into 4 groups which include normal rats (Control; n=12), ISO-MI rats (n=12) which were injected with 85 mg/kg of ISO for 2 days. ISO+CC rats (n=12) were pre and post-treated with CC (30 mg/kg). CC alone rats (n=12) were injected with only CC (30 mg/kg). Pre and post-treatment with CC after and before ISO exposure showed strong cardioprotective property through significant reduction (p<0.05) in the mean values of cardiac infarct size, serum cardiac markers, inflammatory markers, apoptotic markers, lipid peroxidation (oxidative stress) by improving antioxidant status as well as reversing all those histopathological changes. Based on the results, we suggest that CC might be useful against MI if consumed along with standard MI medication to lower cardiac dysfunction and its related complications. However, further studies are needed to justify the above statement.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33361020

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  2 in total

1.  Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT-IKK/STAT3 Axis.

Authors:  Xiaoping Wang; Weili Li; Yawen Zhang; Qianbin Sun; Jing Cao; NanNan Tan; Shuangjie Yang; Linghui Lu; Qian Zhang; Peng Wei; Xiao Ma; Wei Wang; Yong Wang
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

2.  Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice.

Authors:  Deshan Yao; Bo Shi; Sichuan Wang; Liuxiang Bao; Meng Tan; Hui Shen; Zhengang Zhang; Xin Pan; Yi Yang; Yong Wu; Kaizheng Gong
Journal:  Drug Des Devel Ther       Date:  2022-04-29       Impact factor: 4.319

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.